Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. (002720)

Market Closed
15 Jun, 06:30
KRX SM KRX SM
3,530. 00
+10
+0.2841%
87.97B Market Cap
- P/E Ratio
30% Div Yield
47,845 Volume
- Eps
3,520
Previous Close
Add Transaction
Day Range
3,515 3,640
Year Range
3,155 5,470
Want to track 002720 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002720 closed today higher at ₩3,530, an increase of 0.2841% from yesterday's close, completing a monthly decrease of -25.1326% or -₩1,185. Over the past 12 months, 002720 stock lost -18.3815%.
002720 pays dividends to its shareholders, with the most recent payment made on Mar 12, 2026. The next estimated payment will be in In 8 months on Mar 12, 2027 for a total of ₩30.
The last earnings report, released on Dec 31, 2016, exceeded the consensus estimates by 19.6395%. On average, the company has surpassed earnings expectations by 2.2577%, based on the last three reports.
Kukje Pharma Co., Ltd. has completed 14 stock splits, with the recent split occurring on Mar 17, 2023.
The company's stock is traded on one exchange.

002720 Chart

People also search for

Tk Chemical Corp.
1,792
+1.4723%
H.S. Industries Co. Ltd.
2,780
+1.0909%
Motrex Co. Ltd.
7,020
+1.1527%
BYC Co Limited Preferred Stock
25,550
+0.9881%
Digital Daesung Co., Ltd.
7,860
-0.3802%

Kukje Pharma Co., Ltd. (002720) FAQ

What is the stock price today?

The current price is ₩3,530.00.

On which exchange is it traded?

Kukje Pharma Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 002720.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 30%.

What is its market cap?

As of today, the market cap is 87.97B.

Has Kukje Pharma Co., Ltd. ever had a stock split?

Kukje Pharma Co., Ltd. had 14 splits and the recent split was on Mar 17, 2023.

Kukje Pharma Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Tae-hoon Nam CEO
KRX SM Exchange
KR7002720001 ISIN
KR Country
247 Employees
12 Mar 2026 Last Dividend
27 Dec 2018 Last Split
- IPO Date

Overview

Kukje Pharma Co., Ltd., founded in 1959 and headquartered in Seongnam-si, South Korea, is an established name in the pharmaceutical industry. This company prides itself on a broad spectrum of activities that cover manufacturing, importing, exporting, selling, and distributing pharmaceutical products. Alongside its core pharmaceutical offerings, Kukje Pharma also ventures into cosmetics and health care products, reflecting a diversified portfolio designed to cater to a wide range of health and wellness needs.

Products and Services

Kukje Pharma Co., Ltd. offers an extensive range of pharmaceutical and health-related products, encompassing everything from raw materials to finished products. The company’s offerings are categorized into different therapeutic and product types, as follows:

  • Cephalosporins, Quinolones, Tetracycline, Aminoglycosides, Macrolides: These are various classes of antibiotics designed to treat bacterial infections, highlighting Kukje Pharma's focus on addressing diverse microbial diseases.
  • Other Antibiotics: Besides the primary categories mentioned, the company also offers a variety of other antibiotic agents to combat a broad spectrum of infectious diseases.
  • Ophthalmic, Antifungal, and Antiviral Agents: Specialized medications aimed at treating eye infections, fungal, and viral infections, representing Kukje Pharma’s commitment to comprehensive infectious disease management.
  • Adrenal Corticosteroids: Steroid hormones that are crucial in managing inflammation and autoimmune diseases, showcasing the company’s involvement in essential therapeutic areas.
  • CNS and Osteoporotic Agents: Medications focused on treating central nervous system disorders and osteoporosis, indicating the company’s attention to both neurological and bone health.
  • Antihistamines, NSAIDs, and Other Analgesics: Represents the company’s efforts to offer solutions for allergy, pain, and inflammation management.
  • Gastrointestinal and Cardiovascular Agents: Medications dedicated to treating disorders of the gastrointestinal tract and heart, reflecting Kukje Pharma's commitment to addressing a wide range of body systems.
  • Antidiabetics: Treatments specifically formulated for managing diabetes, underscoring the company’s role in combating this global health issue.
  • Genitourinary and Respiratory Agents: Products aimed at treating diseases of the genitourinary and respiratory systems, highlighting Kukje Pharma’s comprehensive approach to medicine.
  • Other ETC products: This category includes a variety of other ethical drugs (prescription based), which speaks to the breadth of Kukje Pharma's pharmaceutical offerings.
  • Cosmetics and Health Care Products: Beyond pharmaceuticals, Kukje Pharma expands its portfolio to include cosmetic and health care products, aiming to contribute to overall health and wellbeing.

Contact Information

Address: 96-8, Yatap-ro, Seongnam-si, South Korea
Phone: 82 3 1781 9081